GI
AGN

Gradient Investments’s Allergan plc AGN Stock Holding History

Gradient Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,190
Closed -$211K – 1277
2020
Q1 		$211K Buy
1,190
+11
+0.9% +$2.07K 0.01% 229
2019
Q4 		$225K Sell
1,179
-20
-2% -$3.61K 0.01% 255
2019
Q3 		$202K Buy
1,199
+21
+2% +$3.42K 0.01% 254
2019
Q2 		$197K Hold
1,178
– – 0.01% 261
2019
Q1 		$172K Sell
1,178
-25
-2% -$3.62K 0.01% 254
2018
Q4 		$161K Buy
1,203
+525
+77% +$86.1K 0.01% 237
2018
Q3 		$129K Buy
678
+598
+748% +$110K 0.01% 265
2018
Q2 		$13K Sell
80
-7
-8% -$1.12K ﹤0.01% 568
2018
Q1 		$15K Buy
87
+82
+1,640% +$13.8K ﹤0.01% 550
2017
Q4 		$1K Buy
+5
New +$897 ﹤0.01% 984
2015
Q3 		– Sell
-25
Closed -$8K – 712
2015
Q2 		$8K Sell
25
-36
-59% -$10.7K ﹤0.01% 419
2015
Q1 		$18K Buy
+61
New +$17.4K ﹤0.01% 330
2014
Q2 		– Sell
-1,032
Closed -$212K – 585
2014
Q1 		$212K Sell
1,032
-29
-3% -$5.74K 0.05% 153
2013
Q4 		$178K Buy
+1,061
New +$166K 0.05% 166
2013
Q3 		– Sell
-717
Closed -$90K – 612
2013
Q2 		$90K Buy
+717
New +$81.2K 0.03% 146

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Gradient Investments's AGN Position: Q2 2020 in Review

Gradient Investments sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,190 shares — an estimated $211K sold.

Gradient Investments first reported a position in AGN in Q2 2013 and held it in 15 quarters. The position peaked at $225K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Gradient Investments reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Gradient Investments sold 1,190 Allergan plc shares in Q2 2020, an estimated $211K.
  • Gradient Investments first reported a position in Allergan plc in Q2 2013 and held it in 15 quarters.
  • Gradient Investments's Allergan plc position peaked at $225K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Gradient Investments's 13F filing for Q2 2020, filed 10 Jul 2020.